PubMed-compiled information sheet
This sheet was compiled from PubMed (NIH) abstracts using AI assistance. Every factual claim is cited to a real PubMed article (see the source list). It has not yet been human-reviewed — confirm with a healthcare provider before use.
Compiled from 12 PubMed articles · model: gemma4:31b
Summary
Background
Traditional uses
Mechanism of action
Clinical evidence
FEWP monotherapy was more effective than placebo, and FEWP combined with conventional anti-depressants (CADs) was more effective than CADs alone [PMID:21820672].
FEWP showed significantly higher clinical response rates (60%) compared to placebo (21.4%) over 8 weeks [PMID:18721085].
As an adjunct to carbamazepine (CBZ), FEWP was associated with a significantly lower overall discontinuation rate (31%) compared to placebo (51%) over 26 weeks [PMID:17010995].
FEWP ameliorated PTSD-like behavior and cognitive impairments in stressed rats [PMID:19665511, PMID:26160034].
FEWP produced anxiolytic-like effects in behavioral models including novelty suppressed feeding and elevated plus-maze tests [PMID:25800108].
Drug interactions
Evidence summary
PubMed sources
- 1.PMID: 40008431 (2025) — Free and Easy Wanderer Ameliorates Intestinal Bloating-Dependent Avoidance Behavior of Caenorhabditis elegans Through Gut-Germline-Neural Signaling. · CNS neuroscience & therapeutics
- 2.PMID: 21820672 (2011) — Meta-analysis of randomized controlled trials to assess the effectiveness and safety of Free and Easy Wanderer Plus, a polyherbal preparation for depressive disorders. · Journal of psychiatric research
- 3.PMID: 28912423 (2017) — The Chinese herbal formula Free and Easy Wanderer ameliorates oxidative stress through KEAP1-NRF2/HO-1 pathway. · Scientific reports
- 4.PMID: 19665511 (2009) — Free and Easy Wanderer Plus (FEWP), a polyherbal preparation, ameliorates PTSD-like behavior and cognitive impairments in stressed rats. · Progress in neuro-psychopharmacology & biological psychiatry
- 5.PMID: 26160034